| Name | Title | Contact Details |
|---|
First aid for when fun wins.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
Kentucky Clinical Research is a Grayson, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Illinois State Medical Society is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
High View Manor is a Madawaska, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.